Researchers launch registry to track rare endocrine tumors
NCT ID NCT03048279
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study gathers health questionnaires from up to 1,500 people with multiple endocrine neoplasia (MEN1 or MEN2) and their close relatives. The goal is to build a database that helps researchers better understand these rare inherited conditions. No new treatments or procedures are being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE ENDOCRINE NEOPLASIA SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New blood test may spot hidden tumors in MEN1 patients
- New drug cocktail aims to shrink Hard-to-Treat carcinoid tumors
- Can Full-Body scans spot cancer early in High-Risk families?
- Hunt for hidden cancer genes: families needed to unlock hereditary secrets
- Massive study aims to unlock secrets of parathyroid diseases